Imbalance of growth factor signalling in diabetic kidney disease: is connective tissue growth factor (CTGF, CCN2) the perfect intervention point?

被引：45
|
作者：
van Nieuwenhoven, FA
Jensen, LJN
Flyvbjerg, A
Goldschmeding, R
机构：
[1] Univ Utrecht, Med Ctr, Dept Pathol, NL-3584 CX Utrecht, Netherlands
[2] Aarhus Univ Hosp, Inst Clin, Med Dept Diabet & Endocrinol, Med Res lABS, DK-8000 Aarhus C, Denmark
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2005年 / 20卷 / 01期
关键词：
clinical marker; CTGF; diabetes; nephropathy; therapy;
D O I：
10.1093/ndt/gfh570
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
引用
收藏
页码：6 / 10
页数：5
相关论文
共 50 条
  • [31] The Role of Tumor Cell-Derived Connective Tissue Growth Factor (CTGF/CCN2) in Pancreatic Tumor Growth
    Bennewith, Kevin L.
    Huang, Xin
    Ham, Christine M.
    Graves, Edward E.
    Erler, Janine T.
    Kambham, Neeraja
    Feazell, Jonathan
    Yang, George P.
    Koong, Albert
    Giaccia, Amato J.
    CANCER RESEARCH, 2009, 69 (03) : 775 - 784
  • [32] Connective Tissue Growth Factor (CTGF/CCN2) Is Negatively Regulated during Neuron-Glioblastoma Interaction
    Romao, Luciana F.
    Mendes, Fabio A.
    Feitosa, Natalia M.
    Faria, Jane Cristina O.
    Coelho-Aguiar, Juliana M.
    de Souza, Jorge Marcondes
    Moura Neto, Vivaldo
    Abreu, Jose Garcia
    PLOS ONE, 2013, 8 (01):
  • [33] Deregulated expression of connective tissue growth factor (CTGF/CCN2) is linked to poor outcome in human cancer
    Wells, Julia E.
    Howlett, Meegan
    Cole, Catherine H.
    Kees, Ursula R.
    INTERNATIONAL JOURNAL OF CANCER, 2015, 137 (03) : 504 - 511
  • [34] Plasma CCN2 (connective tissue growth factor; CTGF) is a potential biomarker in idiopathic pulmonary fibrosis (IPF)
    Kono, Masato
    Nakamura, Yutaro
    Suda, Takafumi
    Kato, Masato
    Kaida, Yusuke
    Hashimoto, Dai
    Inui, Naoki
    Hamada, Etsuko
    Miyazaki, Osamu
    Kurashita, Syunsuke
    Fukamachi, Isamu
    Endo, Koki
    Ng, Poh-Sing
    Takehara, Kazuhiko
    Nakamura, Hirotoshi
    Maekawa, Masato
    Chida, Kingo
    CLINICA CHIMICA ACTA, 2011, 412 (23-24) : 2211 - 2215
  • [35] Connective tissue growth factor (CTGF/CCN2) reinforces the molecular phenotype of aauricular chondrocytes in vitro.
    Fujisawa, T
    Nakao, K
    Hattori, T
    Kubota, S
    Kuboki, T
    Takigawa, M
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (09) : S197 - S197
  • [36] Expression and localization of connective tissue growth factor (CTGF/Hcs24/CCN2) in osteoarthritic cartilage
    Omoto, S
    Nishida, K
    Yamaai, Y
    Shibahara, M
    Nishida, T
    Doi, T
    Asahara, H
    Nakanishi, T
    Inoue, H
    Takigawa, M
    OSTEOARTHRITIS AND CARTILAGE, 2004, 12 (10) : 771 - 778
  • [37] Differential regulation of connective tissue growth factor (CTGF/CCN2) expression in hepatic stellate cells and hepatocytes
    Gressner, O.
    Lahme, B.
    Weiskirchen, R.
    Herrmann, J.
    Gressner, A. M.
    EUROPEAN JOURNAL OF CELL BIOLOGY, 2007, 86 : 46 - 46
  • [38] Osmolarity and calcium regulate connective tissue growth factor (CTGF/CCN2) expression in nucleus pulposus cells
    Lin, Wenbo
    Shi, Changgui
    Wang, Weiheng
    Wu, Huiqiao
    Yang, Chen
    Wang, An
    Shen, Xiaolong
    Tian, Ye
    Cao, Peng
    Yuan, Wen
    GENE, 2019, 704 : 15 - 24
  • [39] Connective Tissue Growth Factor-(CTGF, CCN2) - A Marker, Mediator and Therapeutic Target for Renal Fibrosis
    Phanish, Mysore K.
    Winn, S. K.
    Dockrell, M. E. C.
    NEPHRON EXPERIMENTAL NEPHROLOGY, 2010, 114 (03): : E83 - E92
  • [40] Connective tissue growth factor (CTGF, CCN2) gene regulation: a potent clinical bio-marker of fibroproliferative disease?
    Andrew Leask
    Sunil K. Parapuram
    Xu Shi-wen
    D. J. Abraham
    Journal of Cell Communication and Signaling, 2009, 3 : 89 - 94
12345